Cargando…

Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study

High grade serous ovarian cancer (HGSOC) retains high molecular heterogeneity and genomic instability, which currently limit the treatment opportunities. HGSOC patients receiving complete cytoreduction (R0) at primary surgery and platinum-based therapy may unevenly experience early disease relapse,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dugo, Matteo, Devecchi, Andrea, De Cecco, Loris, Cecchin, Erika, Mezzanzanica, Delia, Sensi, Marialuisa, Bagnoli, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770978/ https://www.ncbi.nlm.nih.gov/pubmed/31491988 http://dx.doi.org/10.3390/genes10090678

Ejemplares similares

The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial–mesenchymal transition, and immune response
por: Devecchi, Andrea, et al.
Publicado: (2018)

Prognostic Evidence of the miRNA-Based Ovarian Cancer Signature MiROvaR in Independent Datasets
por: De Cecco, Loris, et al.
Publicado: (2021)

The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
por: Smith, Philip, et al.
Publicado: (2023)

Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients
por: Bagnoli, Marina, et al.
Publicado: (2011)

Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients
por: Bagnoli, Marina, et al.
Publicado: (2011)

Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer
por: Sun, Yan, et al.
Publicado: (2015)

Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
por: Smith, Philip, et al.
Publicado: (2023)

Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients
por: Vergani, Elisabetta, et al.
Publicado: (2021)

FocalCall: An R Package for the Annotation of Focal Copy Number Aberrations
por: Krijgsman, Oscar, et al.
Publicado: (2014)

Recurrent Somatic Copy Number Alterations and Their Association with Oncogene Expression Levels in High-Grade Ovarian Serous Carcinoma
por: Esplen, Hillary P., et al.
Publicado: (2023)

A miRNA signature assessing ovarian cancer prognosis
por: Bagnoli, Marina, et al.
Publicado: (2016)

A Cross-Comparison of High-Throughput Platforms for Circulating MicroRNA Quantification, Agreement in Risk Classification, and Biomarker Discovery in Non-Small Cell Lung Cancer
por: Gargiuli, Chiara, et al.
Publicado: (2022)

Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
por: Martins, Filipe Correia, et al.
Publicado: (2022)

Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells
por: Rizzo, Andrea, et al.
Publicado: (2021)

Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors
por: Minna, Emanuela, et al.
Publicado: (2023)

Association of Copy Number Variation Signature and Survival in Patients With Serous Ovarian Cancer
por: Graf, Ryon P., et al.
Publicado: (2021)

Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer
por: Silvestri, Marco, et al.
Publicado: (2022)

An IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor response
por: Pinciroli, Patrizia, et al.
Publicado: (2013)

Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas.
por: Tapper, J., et al.
Publicado: (1997)

Focal DNA Copy Number Changes in Neuroblastoma Target MYCN Regulated Genes
por: Kumps, Candy, et al.
Publicado: (2013)

BRCA1/2 variants and copy number alterations status in non familial triple negative breast cancer and high grade serous ovarian cancer
por: El Ansari, Fatima Zahra, et al.
Publicado: (2022)

Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth
por: Rea, Katia, et al.
Publicado: (2018)

One-Carbon Metabolism: Biological Players in Epithelial Ovarian Cancer
por: Rizzo, Andrea, et al.
Publicado: (2018)

Does copy number variation of APOL1 gene affect the susceptibility to focal segmental glomerulosclerosis?
por: Peng, Ting, et al.
Publicado: (2017)

Identification of recurrent focal copy number variations and their putative targeted driver genes in ovarian cancer
por: Zhang, Liangcai, et al.
Publicado: (2016)

Hierarchical discovery of large-scale and focal copy number alterations in low-coverage cancer genomes
por: Khalil, Ahmed Ibrahim Samir, et al.
Publicado: (2020)

In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian Cancer
por: Canese, Rossella, et al.
Publicado: (2016)

Increased Sensitivity to Chemotherapy Induced by CpG-ODN Treatment Is Mediated by microRNA Modulation
por: De Cecco, Loris, et al.
Publicado: (2013)

Comparable Genomic Copy Number Aberrations Differ across Astrocytoma Malignancy Grades
por: Pećina-Šlaus, Nives, et al.
Publicado: (2019)

Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma
por: Conconi, Donatella, et al.
Publicado: (2016)

Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)

Genome-Wide Copy Number Variation in Epilepsy: Novel Susceptibility Loci in Idiopathic Generalized and Focal Epilepsies
por: Mefford, Heather C., et al.
Publicado: (2010)

Navigated focal laser photocoagulation for central serous chorioretinopathy
por: Chhablani, Jay, et al.
Publicado: (2014)

BRAF, GNAQ, and GNA11 mutations and copy number in pediatric low-grade glioma
por: Laviv, Yosef, et al.
Publicado: (2012)

Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma
por: Buchwald, Zachary S., et al.
Publicado: (2020)

Ovarian cancer: a molecularly insidious disease
por: Mezzanzanica, Delia
Publicado: (2015)

Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS)
por: Garziera, Marica, et al.
Publicado: (2018)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Genome Wide DNA Copy Number Analysis of Serous Type Ovarian Carcinomas Identifies Genetic Markers Predictive of Clinical Outcome
por: Engler, David A., et al.
Publicado: (2012)

Copy-number-variation and copy-number-alteration region detection by cumulative plots
por: Li, Wentian, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_9h6sc4vk344cpd7f3qqqk02iq7